Unknown. Condition: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Unknown. Condition: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.
Language: English
Published by Harlequin Enterprises ULC, 2008
ISBN 10: 0373793790 ISBN 13: 9780373793792
Seller: Better World Books, Mishawaka, IN, U.S.A.
Condition: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Language: English
ISBN 10: 1398854255 ISBN 13: 9781398854253
Seller: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Hardcover. Condition: Very Good. No Jacket. Missing dust jacket; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Language: English
Published by Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Published by Performance Programme Dated Saturday 18th March . 2000., 2000
Seller: Little Stour Books PBFA Member, Canterbury, United Kingdom
Association Member: PBFA
US$ 10.87
Quantity: 1 available
Add to basketCondition: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Published by Performance Programme Dated Saturday 2nd March . 2002., 2002
Seller: Little Stour Books PBFA Member, Canterbury, United Kingdom
Association Member: PBFA
US$ 10.87
Quantity: 1 available
Add to basketCondition: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Published by Performance Programme Dated Saturday 12th March . 1994., 1994
Seller: Little Stour Books PBFA Member, Canterbury, United Kingdom
Association Member: PBFA
US$ 10.87
Quantity: 1 available
Add to basketCondition: Fine. Original stapled illustrated souvenir programme. 8½'' x 5½''. Contains 20 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Published by Performance Programme Dated Saturday 2nd March . 2002., 2002
Seller: Little Stour Books PBFA Member, Canterbury, United Kingdom
Association Member: PBFA
US$ 10.87
Quantity: 1 available
Add to basketCondition: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Language: English
Published by Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 136.28
Quantity: Over 20 available
Add to basketCondition: New. In.
Language: English
Published by Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Language: English
Published by Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 136.26
Quantity: Over 20 available
Add to basketCondition: New.
Language: English
Published by Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: Rarewaves USA, OSWEGO, IL, U.S.A.
Hardback. Condition: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Language: English
Published by Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
US$ 170.77
Quantity: Over 20 available
Add to basketHardback. Condition: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Language: English
Published by Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 160.27
Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
Language: English
Published by Emerald Publishing Limited, 2008
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: Mispah books, Redhill, SURRE, United Kingdom
US$ 149.41
Quantity: 1 available
Add to basketHardcover. Condition: Like New. Like New. book.
Language: English
Published by Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Language: English
Published by Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: Rarewaves USA United, OSWEGO, IL, U.S.A.
Hardback. Condition: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Seller: Revaluation Books, Exeter, United Kingdom
US$ 238.15
Quantity: 2 available
Add to basketHardcover. Condition: Brand New. 250 pages. 9.25x6.25x1.25 inches. In Stock.
Language: English
Published by Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: Rarewaves.com UK, London, United Kingdom
US$ 165.90
Quantity: Over 20 available
Add to basketHardback. Condition: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Language: English
Published by Emerald Group Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
US$ 141.38
Quantity: Over 20 available
Add to basketHRD. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Language: English
Published by Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
US$ 163.02
Quantity: Over 20 available
Add to basketHardback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Seller: moluna, Greven, Germany
US$ 188.06
Quantity: Over 20 available
Add to basketCondition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. InhaltsverzeichnisContents: Introduction (I. Farquhar, K. Summers, A. Sorkin). INNOVATION IN REGULATORY AND OUTCOMES RESEARCH APPLICATIONS (1) After-Market Drug Regulation: Promoting Public Trust in Innovation (R. Field) (2) Transcendin.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. Print on Demand pp. 250.
Seller: Majestic Books, Hounslow, United Kingdom
US$ 261.31
Quantity: 4 available
Add to basketCondition: New. Print on Demand pp. 250.
Seller: preigu, Osnabrück, Germany
Buch. Condition: Neu. Value of Innovation | Irina Farquhar (u. a.) | Buch | Gebunden | Englisch | 2008 | Jai Press Inc. | EAN 9780762313464 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND pp. 250.
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs.